Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yuji Ishida

Showing results (161-170 of 191) with videos related to

Pageof 20
Sort By:
Virus Research|November 17, 2015
Elimination of HCV via a non-ISG-mediated mechanism by vaniprevir and BMS-788329 combination therapy in human hepatocyte chimeric miceTakuro Uchida, Nobuhiko Hiraga, Michio Imamura, et al.
Plos Computational Biology|August 3, 2023
Modeling suggests that virion production cycles within individual cells is key to understanding acute hepatitis B virus infection kineticsAtesmachew Hailegiorgis, Yuji Ishida, Nicholson Collier, et al.
Scientific Reports|December 31, 2024
Theoretical modeling of hepatitis C acute infection in liver-humanized mice support pre-clinical assessment of candidate viruses for controlled-human-infection studiesZhenzhen Shi, Adquate Mhlanga, Yuji Ishida, et al.
The Journal of General Virology|February 1, 2017
Usefulness of humanized cDNA-uPA/SCID mice for the study of hepatitis B virus and hepatitis C virus virologyTakuro Uchida, Michio Imamura, Hiromi Kan, et al.
Biochemical and Biophysical Research Communications|April 6, 2018
Prevalence of NS5A resistance associated variants in NS5A inhibitor treatment failures and an effective treatment for NS5A-P32 deleted hepatitis C virus in humanized miceYuji Teraoka, Takuro Uchida, Michio Imamura, et al.
International Journal of Molecular Sciences|February 25, 2023
NF-κB Decoy ODN-Loaded Poly(Lactic-co-glycolic Acid) Nanospheres Inhibit Alveolar Ridge ResorptionAlbert Chun-Shuo Huang, Yuji Ishida, Kai Li, et al.
The Journal of Infectious Diseases|September 22, 2016
Protease Inhibitor Resistance Remains Even After Mutant Strains Become Undetectable by Deep SequencingHiromi Kan, Michio Imamura, Takuro Uchida, et al.
Heart and Vessels|November 12, 2013
Low serum eicosapentaenoic acid level is a risk for ventricular arrhythmia in patients with acute myocardial infarction: a possible link to J-wavesTomohide Endo, Hirofumi Tomita, Takumi Higuma, et al.
Antimicrobial Agents and Chemotherapy|July 12, 2017
Persistent Loss of Hepatitis B Virus Markers in Serum without Cellular Immunity by Combination of Peginterferon and Entecavir Therapy in Humanized MiceTakuro Uchida, Michio Imamura, C Nelson Hayes, et al.
JHEP Reports : Innovation in Hepatology|November 28, 2022
Downregulation of SOCS1 increases interferon-induced ISGylation during differentiation of induced-pluripotent stem cells to hepatocytesJasmine S Edwards, Stephanie A Delabat, Alejandro D Badilla, et al.
Pageof 20

Showing results (161-170 of 191) with videos related to

Sort By:
Pageof 20
Virus Research|November 17, 2015
Elimination of HCV via a non-ISG-mediated mechanism by vaniprevir and BMS-788329 combination therapy in human hepatocyte chimeric miceTakuro Uchida, Nobuhiko Hiraga, Michio Imamura, et al.
Plos Computational Biology|August 3, 2023
Modeling suggests that virion production cycles within individual cells is key to understanding acute hepatitis B virus infection kineticsAtesmachew Hailegiorgis, Yuji Ishida, Nicholson Collier, et al.
Scientific Reports|December 31, 2024
Theoretical modeling of hepatitis C acute infection in liver-humanized mice support pre-clinical assessment of candidate viruses for controlled-human-infection studiesZhenzhen Shi, Adquate Mhlanga, Yuji Ishida, et al.
The Journal of General Virology|February 1, 2017
Usefulness of humanized cDNA-uPA/SCID mice for the study of hepatitis B virus and hepatitis C virus virologyTakuro Uchida, Michio Imamura, Hiromi Kan, et al.
Biochemical and Biophysical Research Communications|April 6, 2018
Prevalence of NS5A resistance associated variants in NS5A inhibitor treatment failures and an effective treatment for NS5A-P32 deleted hepatitis C virus in humanized miceYuji Teraoka, Takuro Uchida, Michio Imamura, et al.
International Journal of Molecular Sciences|February 25, 2023
NF-κB Decoy ODN-Loaded Poly(Lactic-co-glycolic Acid) Nanospheres Inhibit Alveolar Ridge ResorptionAlbert Chun-Shuo Huang, Yuji Ishida, Kai Li, et al.
The Journal of Infectious Diseases|September 22, 2016
Protease Inhibitor Resistance Remains Even After Mutant Strains Become Undetectable by Deep SequencingHiromi Kan, Michio Imamura, Takuro Uchida, et al.
Heart and Vessels|November 12, 2013
Low serum eicosapentaenoic acid level is a risk for ventricular arrhythmia in patients with acute myocardial infarction: a possible link to J-wavesTomohide Endo, Hirofumi Tomita, Takumi Higuma, et al.
Antimicrobial Agents and Chemotherapy|July 12, 2017
Persistent Loss of Hepatitis B Virus Markers in Serum without Cellular Immunity by Combination of Peginterferon and Entecavir Therapy in Humanized MiceTakuro Uchida, Michio Imamura, C Nelson Hayes, et al.
JHEP Reports : Innovation in Hepatology|November 28, 2022
Downregulation of SOCS1 increases interferon-induced ISGylation during differentiation of induced-pluripotent stem cells to hepatocytesJasmine S Edwards, Stephanie A Delabat, Alejandro D Badilla, et al.
Pageof 20